​

PROCEPT BioRobotics (PRCT) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PRCT Stock Forecast

PROCEPT BioRobotics (PRCT) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $105.00, with a high of $105.00 and a low of $105.00. This represents a 43.93% increase from the last price of $72.95.

$40 $53 $66 $79 $92 $105 High: $105 Avg: $105 Low: $105 Last Closed Price: $72.95

PRCT Stock Rating

PROCEPT BioRobotics stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (83.33%), 1 Hold (16.67%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 1 5 0 Strong Sell Sell Hold Buy Strong Buy

PRCT Forecast vs Benchmarks

TypeNameUpside
StockPROCEPT BioRobotics43.93%
SectorHealthcare Stocks 25.20%
IndustryMedical Device Stocks6.39%

Price Target Trends

1M3M12M
# Anlaysts-16
Avg Price Target-$105.00$88.50
Last Closing Price$72.95$72.95$72.95
Upside/Downside-43.93%21.32%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25262--10
Dec, 24262--10
Nov, 24352--10
Oct, 24351--9
Sep, 24351--9
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 02, 2024Patrick WoodMorgan Stanley$105.00$94.9310.61%43.93%
Oct 29, 2024Richard NewitterTruist Financial$105.00$96.249.10%43.93%
Sep 03, 2024Richard NewitterTruist Financial$95.00$79.0020.25%30.23%
Jul 16, 2024Richard NewitterTruist Financial$79.00$68.9014.66%8.29%
May 06, 2024Matt O'BrienPiper Sandler$75.00$64.3116.62%2.81%
May 02, 2024Richard NewitterTruist Financial$72.00$60.6118.79%-1.30%
Sep 02, 2022Nathan TreybeckWells Fargo$49.00$40.3821.35%-32.83%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Dec 02, 2024Morgan StanleyOverweightinitialise
Oct 29, 2024BTIGNeutralNeutralhold
Oct 28, 2024William BlairOutperformOutperformhold
Oct 08, 2024Truist FinancialUnderperformUnderperformhold
Sep 16, 2024Cowen & Co.BuyBuyhold
Jul 02, 2024Cowen & Co.BuyBuyhold
May 06, 2024Cowen & Co.BuyBuyhold
May 06, 2024Piper SandlerOverweightOverweighthold

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.43$-2.11$-2.24-----
Avg Forecast$-3.04$-1.88$-2.14$-1.74$-1.30$-0.76$-0.02$0.56
High Forecast$-3.12$-1.95$-2.23$-1.83$-1.55$-1.05$-0.02$0.54
Low Forecast$-2.93$-1.81$-2.08$-1.69$-1.04$-0.56$-0.02$0.58
Surprise %-52.96%12.23%4.67%-----

Revenue Forecast

$0 $130M $260M $390M $520M $650M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$34.47M$75.01M$136.19M-----
Avg Forecast$33.37M$74.15M$134.44M$223.93M$315.00M$415.28M$516.98M$624.64M
High Forecast$32.44M$72.02M$129.50M$223.77M$311.07M$414.13M$505.38M$601.68M
Low Forecast$34.07M$76.43M$138.14M$224.04M$318.36M$416.43M$528.59M$641.83M
Surprise %3.31%1.16%1.30%-----

Net Income Forecast

$-150M $-110M $-70M $-30M $10M $50M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-62.38M$-93.58M$-105.90M-----
Avg Forecast$-143.66M$-88.84M$-101.72M$-83.22M$-70.45M$-43.55M$-1.10M$26.62M
High Forecast$-147.59M$-92.38M$-105.24M$-86.51M$-73.37M$-49.54M$-1.14M$25.35M
Low Forecast$-138.46M$-85.51M$-98.19M$-79.93M$-49.23M$-26.33M$-1.05M$27.57M
Surprise %-56.57%5.34%4.11%-----

PRCT Forecast FAQ

Is PROCEPT BioRobotics stock a buy?

PROCEPT BioRobotics stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that PROCEPT BioRobotics is a favorable investment for most analysts.

What is PROCEPT BioRobotics's price target?

PROCEPT BioRobotics's price target, set by 6 Wall Street analysts, averages $105 over the next 12 months. The price target range spans from $105 at the low end to $105 at the high end, suggesting a potential 43.93% change from the previous close price of $72.95.

How does PROCEPT BioRobotics stock forecast compare to the average forecast of its sector, industry, and investment themes?

PROCEPT BioRobotics stock forecast shows a 43.93% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the medical device stocks industry (6.39%).

What is the breakdown of analyst ratings for PROCEPT BioRobotics over the past three months?

  • January 2025: 20.00% Strong Buy, 60.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 20.00% Strong Buy, 60.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 30.00% Strong Buy, 50.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.

What is PROCEPT BioRobotics’s EPS forecast?

PROCEPT BioRobotics's average annual EPS forecast for its fiscal year ending in December is -1.74 for 2024, a -22.32% decrease from the reported $-2.24 in 2023. The prediction for 2025 is $-1.3, $-0.76 for 2026, $-0.02 for 2027, and $0.56 for 2028.

What is PROCEPT BioRobotics’s revenue forecast?

PROCEPT BioRobotics's average annual revenue forecast for its fiscal year ending in December is $223.93M for 2024, a 64.42% increase from the reported $136.19M in 2023. The forecast for 2025 is $315M, $415.28M for 2026, $516.98M for 2027, and $624.64M for 2028.

What is PROCEPT BioRobotics’s net income forecast?

For its fiscal year ending in December, PROCEPT BioRobotics's average annual net income forecast is $-83.219M for 2024, reflecting a -21.41% decrease from the reported $-106M in 2023. The projection for 2025 is $-70.45M, $-43.549M for 2026, $-1.096M for 2027, and $26.62M for 2028.